Isoprenyl compounds and methods thereof
Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.
1. A compound of the structure:
2. A compound of the structure:
or a pharmaceutically acceptable salt thereof.
3. A composition comprising a compound according to claim 2 and a pharmaceutically acceptable adjuvant, carrier or vehicle.
4. A composition comprising:
a compound of the structure
or a pharmaceutically acceptable salt thereof, and
a pharmaceutically acceptable adjuvant, carrier, or vehicle.
5. The composition of claim 4 , wherein the composition is in the form of a gel suspension.
6. The composition of claim 4 , further comprising a therapeutic agent selected from the group consisting of dexamethasone, indomethacin and clobetasol,
7. The composition of claim 4 , wherein the composition is suitable for oral use.